Sign in / Create account
Express Scripts Holding Company Announces Fourth Quarter and Full Year 2016 Earnings Conference Call
GlobeNewswire

ST. LOUIS, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) (“Express Scripts”) announced today its intention to release its 2016 fourth quarter and full year financial results on Tuesday, February 14, 2017 after the market closes and will hold its quarterly conference call to discuss 2016 fourth quarter and full year financial results on Wednesday, February 15, 2017, at 8:30 a.m. EST (7:30 a.m. CST). 

The call includes a slide presentation and is being webcast via the Internet and can be accessed at the Investor Relations section of Express Scripts’ web site at http://www.express-scripts.com/corporate.  RealPlayer or Windows Media Player is needed to listen to the webcast and free downloads of these players are available at the broadcast site. Both the slide presentation and the webcast will remain available on the Investor Relations section of Express Scripts’ website for 90 days.

About Express Scripts

Express Scripts puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services.  Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

Contact:									
Eric Slusser, Chief Financial Officer			
Ben Bier, Vice President Investor Relations			
(314) 810-3115								
investor.relations@express-scripts.com

© Alipes Capital ApS 2024